Work

Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2

Year: 2019

Type: article

Source: Nanomedicine Nanotechnology Biology and Medicine

DOI: 10.1016/j.nano.2019.102076

Authors: Christina L. Parker, Morgan D. McSweeney, Andrew T. Lucas, Timothy M. Jacobs, Daniel Wadsworth, William C. Zamboni, Samuel K. Lai

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Science Foundation, David and Lucile Packard Foundation, North Carolina Biotechnology Center, China Postdoctoral Science Foundation, National Institutes of Health, University of North Carolina at Chapel Hill, Research Opportunities Initiative, University of North Carolina, Directorate for STEM Education, National Heart, Lung, and Blood Institute, National Cancer Institute, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Eshelman Institute for Innovation, University of North Carolina at Chapel Hill

Awards: G2297115196, Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics, Cancer Center Support Grant

OpenAlex ID: W2966501874

FWCI: 0.845

Cites: 47

Cited by: 23

Related to: 10